January 28, 2013

In a shot that made the rounds Friday on ESPN and other sports shows, Miami Heat fan Michael Drysch drained a half-court shot in the Carmex Half-Court Hero contest, netting $75,000 and getting tackled by Miami Heat superstar LeBron James.

January 18, 2013

Costco announced in its January 2013 magazine that it would begin offering pharmacy benefit management services, targeting small businesses and highlighting a 200-employee company based in Washington state.

It remains to be seen whether the club retailer's efforts to compete with the existing PBM businesses of companies like CVS Caremark, Walgreens and Walmart will be successful, and analysts like Citi's Deborah Weinswig appear skeptical that they will. But whatever the outcome, it's clear that Costco is looking to compete in a bigger way.

January 11, 2013

Last week in a much anticipated move, Cerberus Capital Management acquired 877 supermarkets from Supervalu for $100 million in cash and the assumption of $3.2 billion in debt. Also part of the deal, a Cerberus-led investor consortium will provide the remaining Supervalu business an influx with the purchase of up to 30% of Supervalu stock at a purchase price of $4 per share.

Following the transaction, Supervalu will be a $17 billion business comprised mostly of its distribution business, which will represent 47% of revenues, Save-A-Lot (25%) and 191 regional supermarkets (28%).

January 7, 2013

Stop & Shop is offering free produce for a year to winners of a healthy eating contest it is sponsoring, the Ahold banner said.

December 7, 2012

CVS Caremark is looking to acquire an 80% stake in Onofre, the eighth-largest pharmacy chain in Brazil, according to published reports.

Are you ready for the globalization of drug store retailing? DSN is. And we expect it to continue. Why? That's where the Rx growth is. Expect more of these deals. Where? Follow the money (i.e., emerging markets where Rx growth is still in high single to low double digits).

November 29, 2012

When Walgreens and Express Scripts finally came to terms and agreed to again do business with each other in mid-2012, it marked the formal end of one of the costliest disputes in the history of pharmacy retailing and managed care. 


November 5, 2012

The opportunity for weight loss certainly hasn’t gone away — sales of diet-aid liquids were up 12.8% to $1.2 billion for the 52 weeks ended Sept. 9 across food, drug and mass (excluding Walmart), according to SymphonyIRI.

October 17, 2012

Over the course of a day-long investor conference Tuesday, Kroger outlined its future growth strategy.

September 28, 2012

The new data by Marketdata Enterprises is significant as it puts a number against a very valuable and fast-growing segment of health care that will continue to grow regardless of who is elected president and what happens to healthcare reform.

September 21, 2012

The National Advertising Division on Thursday recommended that Church & Dwight discontinue its claim that the company’s First Response digital ovulation test is the “first and only test to predict ovulation based on your unique LH hormone level.”

September 20, 2012

With the dispute between Walgreens and Express Scripts over, one of the biggest challenges for Rite Aid will be retaining the customers it won over during the impasse.

September 19, 2012

While holiday retail sales will remain flat or only slightly up from last year, emerging consumer buying trends will have significant implications for retailers, according to a new survey from Booz & Co.

September 18, 2012

Generic drug makers Hospira, Sagent Pharmaceuticals and Teva Pharmaceutical Industries have launched generic versions of a chemotherapy drug made by Sanofi, the three companies said last month.


September 18, 2012

For branded drug makers, the pharmaceutical patent cliff has never loomed higher or steeper. The exposure of so many of the world’s biggest-selling medicines to generic competition for the first time is redefining the pricing model for many of the most widely prescribed classes of pharmaceuticals.

September 17, 2012

ProPhase Labs on Monday announced that it rejected an unsolicited, nonbinding proposal from Matrixx Initiatives to acquire the company for $1.40 per share in cash, subject to further due diligence by Matrixx.

September 7, 2012

Perrigo is seeking regulatory approval for what it called the first generic version of a drug for treating bronchospasm.

August 20, 2012

Bayer has been stepping up its game behind its Bayer Advanced Aspirin brand in an attempt to recreate its brand identity from a healthy heart supplement for people who’ve had a heart attack to what Bayer Aspirin had been in its heyday: the internal analgesic of choice.

August 17, 2012

Procter & Gamble’s Prilosec OTC still is the best-selling antacid on the market, with more than $252.7 million in annual sales for the 52 weeks ended July 8 across food, drug and mass (excluding Walmart), followed by fellow proton-pump inhibitor Novartis’ Prevacid 24HR ($104.1 million).


August 10, 2012

Albertsons Market has launched a month-long contest asking customers to share their “Best Road Trip. Ever!” through photos, videos and essays on Albertsons Markets’ Facebook fan page for a chance to win a new car.

July 30, 2012

Everybody loves a comeback story, and it looks as though the pharmacy retail industry has one of its own in the making as Rite Aid’s latest earnings report showed another strong quarter for the Camp Hill, Pa.-based chain, which has been steadily growing its sales and narrowing its losses for several quarters already.


July 23, 2012

So Walgreens and Express Scripts have buried the hatchet. The question is, can the nation’s top pharmacy retailer regain the billions of dollars in contracted prescription revenues it ceded to its competitors after the two sides severed relations in January? And, given the way Walgreens has adjusted and reset its growth strategy since then, does it matter that much?

July 12, 2012

Supervalu on Thursday announced a number of dramatic measures to stabilize its business — reduction in capital spending, suspension of the company's dividend, even the exploration of possible strategic alternatives — in conjunction with its declining first-quarter earnings results.

July 6, 2012

The trend toward “narrow” pharmacy networks is expected to continue, according to a Wall Street Journal report.

June 28, 2012

Mylan is challenging the patent protection on a Pfizer drug for treating depression, following an announcement of a similar challenge by Watson made earlier this week.